News

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line therapies. Boris Pasche, M.D., Ph.D., FACP , president and CEO of the Barbara Ann Karmanos Cancer Institute, chair of the Department of Oncology at Wayne State University, and co-inventor of the TheraBionic P1 device, and Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team ,...

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announced today that the new TheraBionic P1 device, an FDA-approved, at-home treatment , is now available to treat advanced liver cancer. Karmanos Cancer Center is the first institution worldwide to prescribe this treatment. The TheraBionic P1 device is a novel, handheld, portable device that produces low levels of 27.12 MHz radiofrequency electromagnetic fields, whic...

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast cancer, including initial and ongoing treatments, biomarkers and overall treatment strategies. Organized by CURE in collaboration with the Office of Cancer Health Equity and Community Engagement (OCHECE) at Karmanos, this event provided an opportunity for community members to engage with experts in metastatic breast cancer, enhancing their understanding of trea...

To celebrate Breast Cancer Awareness Month, a unique mobile entertainment company, Paint’d Party Services, decided to help bring some joy to cancer survivors by donating painting kits, an item used frequently by the Barbara Ann Karmanos Cancer Institute’s Healing Arts Program.  “Donations like these are instrumental in making sure we can help create joy in the lives of cancer survivors,” said Greg Cascione, Ph.D., philanthropy officer at Karmanos. “Being able to provide these activities and experie...

WDET A foundation will offer scholarships and internships to medical students for assistance in recruiting underrepresented and disadvantaged individuals into clinical trials. Hayley Thompson, Ph.D., associate center director of Community Outreach and Education at Karmanos Cancer Institute and faculty supervisor of Karmanos’ Office of Cancer Health Equity and Community Engagement , applauded this work and explained why it's important for patients of color to consider participating in clinical trials. Sh...

Your genes determine your eye color and height, and they may also reveal your cancer risk. Having a family history of certain types of cancer can increase your risk of developing the disease. There is a lot of information out there about genetics and cancer risk, and sifting through it can be overwhelming and confusing. But you don’t have to do it alone. The Karmanos Cancer Institute genetic counseling service is available to patients throughout the Karmanos Cancer Network. “Genetic counselors have adva...

Clinical Leader As we approach a new year, Clinical Leader asked clinical trials professionals about the success and future outlook of using decentralized clinical trials (DCT). Wasif Saif, M.D., MBBS , medical oncologist and leader of the Phase I Clinical Trials Multidisciplinary Team at Karmanos, explained how DCTs have provided access to many cancer patients, and what should be considered when designing a trial. Read the article here .

Healio Do you understand how clinical trials work in oncology? Wasif Saif, M.D., MBBS , medical oncologist, leader of the  Phase I Clinical Trials Multidisciplinary Team (MDT) and co-leader of the  Gastrointestinal and Neuroendocrine Oncology MDT , debunked a common myth about clinical trials for cancer and explained why there are no placebos in phase I trials. Read the article here . Learn more about clinical trials at Karmanos here .

Though rare in the U.S., stomach cancer makes up about 1.5% of all cancer diagnoses annually. The American Cancer Society estimates that over 26,800 people will be diagnosed with stomach cancer in 2024. Also known as gastric cancer, it’s a disease that is usually detected in patients in their upper 60s, affecting more men than women. Signs & Symptoms of Stomach Cancer Due to stomach cancer being rare in the U.S., there are no standard guidelines for routine screening for average-risk people, so it i...

WebMD Breast cancer survivors have turned the in-person support group into a thread on Reddit. Researchers at the University of Colorado Anschutz Medical Campus in Denver found themes of advice, affirmation, venting, solidarity, and motivation, among other topics discussed in over 700 posts. Though peer support is present, Mary Morreale, M.D. , clinical psychiatrist and member of the Supportive Oncology Multidisciplinary Team at Karmanos, explained why survivors will need to find a delicate balance with...